Safety and efficacy in actual clinical practice of once-weekly subcutaneous teriparatide for osteoporosis patients with a high fracture risk

OBJECTIVES: To reassess the safety and efficacy of once-weekly teriparatide 56.5 μg in osteoporosis patients with a high fracture risk. METHODS: This postmarketing observational study was conducted at 72 weeks according to the package insert. Of the 3573 Japanese osteoporosis patients in the safety...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Osteoporos Sarcopenia
Главные авторы: Ifuku, Emiko, Yoshimura, Takeshi, Uzawa, Toyonobu, Hokonohara, Tadami
Формат: Artigo
Язык:Inglês
Опубликовано: Korean Society of Osteoporosis 2019
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6626839/
https://ncbi.nlm.nih.gov/pubmed/31338434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.afos.2019.06.002
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы